# Dysfunction of the episodic memory network in the Alzheimer's disease cascade.

- **DOI:** [10.1038/s41467-026-71831-z](https://doi.org/10.1038/s41467-026-71831-z)
- **Rating:** Sound (3.1 out of 5)
- **Verdict:** A substantive longitudinal fMRI extension of the ATN framework whose causal interpretation exceeds what its observational, model-derived evidence can establish.
- **Framework version:** v5.9
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-10-08
- **Evaluation page:** https://www.nabu.science/paper/10.1038%2Fs41467-026-71831-z

## Key claims

1. Trajectories for the loss of deactivation were nonlinear, associated with amyloid- and tau-positivity and visually preceded trajectories of cognitive decline.
   - Support: Supported
   - Type: Primary finding
   - Basis: model-derived timing and a small nonlinear effect support the direction but limit temporal certainty
   - Location: Abstract; Results, “Towards task-activity based AD biomarker progression curves,” Figs. 1b and 2c
2. The relationship between deactivation and cognitive decline was partly independent of neurodegeneration.
   - Support: Tentative
   - Type: Secondary
   - Basis: cross-sectional adjusted associations measure cognitive level rather than longitudinal decline
   - Location: Abstract; Results, “Subsequent memory is associated with individual biomarkers,” Fig. 3d–e
3. Our results provide evidence that synaptic dysfunction and neurodegeneration are independent drivers of cognitive decline.
   - Support: Tentative
   - Type: Secondary
   - Basis: observational BOLD associations and mediation cannot identify independent causal drivers
   - Location: Abstract, final sentence
4. Voxel-wise analyses revealed widespread loss of deactivation and activation with disease progression.
   - Support: Supported
   - Type: Secondary
   - Basis: FWE-corrected full-sample results support the pattern, though the activation finding weakened in sensitivity analysis
   - Location: Abstract; Results, “Encoding-related brain activity changes with progression towards AD,” Fig. 2b

## Strengths

- **Large longitudinal task-fMRI resource** The analysis draws on 493 baseline fMRI participants and longitudinal scans across four time points, providing unusual scale for an AD task-fMRI study.
  - Dimension: contribution
  - Location: Methods, “Participants”; Results, “Longitudinal activation change is moderated by disease stage”
- **Multiple converging analytical approaches** Voxelwise FWE-controlled analyses are supplemented by biomarker-specific adjustment, mediation models, residual-variability checks, and longitudinal moderation tests.
  - Dimension: methodological rigour
  - Location: Results, Figs. 2–5; Methods, “Statistical analyses”
- **Broad engagement with alternatives** The paper considers atrophy, white-matter hyperintensities, effective connectivity, vascular contributions, dedifferentiation, regression to the mean, and measurement variability.
  - Dimension: positioning
  - Location: Introduction, competing mechanisms; Discussion, limitations

## Limitations

- **Causal conclusions exceed observational design** Adjusted associations and cross-sectional mediation do not establish that synaptic dysfunction is an independent driver or probable cause of cognitive impairment, nor that the inferred cascade is confirmed.
  - Dimension: methodological rigour
  - Location: Abstract, final sentence; Discussion, extended ATN model paragraph; Fig. 6 legend
- **Model timing carries substantial uncertainty** The fMRI trajectory is derived from activity clusters selected for disease-stage association, and no uncertainty interval is reported for its fastest-change time. The disease model also assumes a shared progression rate.
  - Dimension: methodological rigour
  - Location: Methods, spline analysis and disease-progression model; Results, Fig. 2c; Discussion, limitations
- **Selection and follow-up remain unresolved** CSF data were available for 218 of 493 participants, the model was fitted in a selected 208-person subgroup, and follow-up availability differed strongly across diagnostic groups without a reported missingness analysis.
  - Dimension: methodological rigour
  - Location: Methods, “Participants” and “Participant selection for the model fit”; Results, longitudinal analysis

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Noted
  - Trajectories for the loss of deactivation were nonlinear, associated with amyloid- and tau-positivity and visually preceded trajectories of cognitive decline: "we used 739 longitudinal ATN biomarker and cognitive measurements from 208 participants with an AD biomarker profile11 to train the probabilistic DP model" (Results, Disease stage associates with several AD-related factors) vs "using 787 available data points from 208 participants (80 CN, 57A+ SCD, 44A+ MCI, 27A+ DAT)." (Figure 1a caption). The text and caption describe the same DPM fitting sample but give input counts differing by 787 − 739 = 48, without explaining a difference in counting units. → Effect on result unclear
  - Minor reporting notes (2):
    - Descriptive: "Ridgeline plots of cross-sectional disease stages in AT classification subgroups (colours) of AD pathology (n = 222)." (Figure 1d caption) vs "CSF biomarker data were available for 218 participants." (Methods, CSF-biomarkers). The AT-classification plot includes 222 participants, four more than the 218 reported to have the CSF data used for AT classification, and the text does not reconcile these counts. → Effect on result unclear
    - Descriptive: "Encoding-related activation was significantly negatively correlated with ADAS-COG-13 (r(157) = −0.19, p = 0.016, 95% CI = [−0.37; −0.08]; Fig. 3d)" (Results, Subsequent memory is associated with individual biomarkers). Assuming an ordinary Pearson correlation with n = 159 inferred from df = 157, a Fisher-z interval calculated from the rounded r = −0.19 is approximately [−0.336, −0.035], rather than [−0.37, −0.08], but both exclude zero; this is approximate because the reported analysis is semi-partial. → Conclusion holds
- **Reporting and transparency:** Noted. The AD-exclusion sensitivity result is disclosed only qualitatively in the limitations, and the longitudinal change–change null results lack coefficients and confidence intervals. Neither omission permits recomputation of the affected estimates.
  - Conflict of interest: not stated · Ethics approval: declared · Preregistration: not stated · Data availability: declared · Code availability: declared
- **Reference integrity:** Clean
  - 86 references in manuscript
  - 84 of 84 checkable references found in an index
  - 2 have no canonical index record — counted, but not index-checkable
  - 2 references confirmed by manual review
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
